 | Up a level |
Keil, Andreas; Hall, Sean; Körner, Meike; Herrmann, Martin; Schmid, Ralph; Frese, Steffen R. (2016). Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan. Arthritis research & therapy, 18(243), p. 243. BioMed Central 10.1186/s13075-016-1144-5
Keil, Andreas; Frese-Schaper, Manuela; Steiner, Selina; Körner, Meike; Schmid, Ralph; Frese, Steffen R. (2015). The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl-DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis. Arthritis & rheumatology, 67(7), pp. 1858-1867. Wiley-Blackwell 10.1002/art.39119
Frese-Schaper, Manuela; Keil, Andreas; Steiner, Selina; Gugger, Mathias; Körner, Meike; Kocher, Gregor; Schiffer, Lena; Anders, Hans-Joachim; Huynh-Do, Uyen; Schmid, Ralph; Frese, Steffen R. (2014). Low dose irinotecan improves advanced lupus nephritis in mice potentially by changing DNA relaxation and anti–double-stranded DNA binding. Arthritis & rheumatology, 66(8), pp. 2259-2269. Wiley-Blackwell 10.1002/art.38665
Frese-Schaper, Manuela; Keil, Andreas; Yagita, Hideo; Steiner, Selina; Falk, Werner; Schmid, Ralph; Frese, Steffen R. (2014). Influence of natural killer cells and perforin-mediated cytolysis on the development of chemically induced lung cancer in A/J mice. Cancer immunology, immunotherapy, 63(6), pp. 571-580. Springer 10.1007/s00262-014-1535-x
